Johnson & Johnson Family of Companies
NEWS
The company posted an interim analysis of its Phase I/IIa trial that showed a single dose of JNJ-78436735 induced a strong neutralizing antibody response in nearly all participants and was well-tolerated.
The European Society of Medical Oncology (ESMO) Virtual Congress 2020 was last weekend and the beginning of the week, which resulted in numerous clinical trial announcements. Here’s a look.
The J&J vaccine appears to require only a single dose. Several of the other candidate vaccines require two doses about 28 days apart.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
Johnson & Johnson has become the next big pharma player to be accused in New York State’s Department of Financial Services opioid industry probe.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
Janssen Pharmaceutical of Johnson & Johnson made a strategic call to halt development of pimodivir, an antiviral treatment for influenza A.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
J&J said the acquisition will allow its subsidiary, Janssen Pharmaceutical, to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease.
JOBS
IN THE PRESS